Additional file 8 of Loss of tumor-derived SMAD4 enhances primary tumor growth but not metastasis following BMP4 signalling

dataset

posted on 2024-08-15, 08:32 authored by Lap Hing Chi, Andrew D. Redfern, Suraya Roslan, Ian P. Street, Allan D. Burrows, Robin L. Anderson

Additional file 8: Supplementary table 2. Western blotting / IHC antibodies used in this study.

Funding

National Health and Medical Research Council Wellcome Trust Cancer Council Victoria

History

Related Materials

1.
DOI - References https://doi.org/10.3322/caac.21660
2.
DOI - References https://doi.org/10.1001/jama.2018.19323
3.
DOI - References https://doi.org/10.1056/NEJMoa1706450
4.
DOI - References https://doi.org/10.1016/S0140-6736(20)32531-9
5.
DOI - References https://doi.org/10.1056/NEJMoa2028485
6.
DOI - References https://doi.org/10.1158/0008-5472.CAN-13-3171
7.
DOI - References https://doi.org/10.1158/0008-5472.CAN-19-0743
8.
DOI - References https://doi.org/10.1038/nrendo.2016.12
9.
DOI - References https://doi.org/10.1073/pnas.1101139108
10.
DOI - References https://doi.org/10.3389/fphar.2019.00667

Usage metrics

Categories

Genetics

Keywords

Breast cancer Metastasis BMP4 SMAD4 MYO1F Patient outcomes

Licence

Exports